MILabs provides high performance standalone and integrated preclinical SPECT, PET, CT and Optical Imaging systems for molecular imaging and in vivo imaging research. The 4x4D multimodal imaging technology, each with four-dimensional imaging capabilities enables researchers to improve diagnostics and therapy development through complementary, data-rich, co-registered images. Each modality by itself gives data beyond the capabilities of any other stand-alone system. Our mission is to make molecular imaging clear. Through continuous innovation and supportive service, the team at MILabs is dedicated to ‘providing small details for big discoveries’ for a wide range of imaging research programs. With over 100 installations worldwide, our fast-growing company collaborates with leading universities, hospitals, contract research organizations and pharmaceutical companies. The systems contribute significantly to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. Explore how the cutting-edge preclinical imaging and clinical technologies can accelerate research discoveries at www.milabs.com